Through the use of our proprietary specimen preparation process, we are able to achieve some of the lowest reportable limits (cut-offs) in the clinical toxicology testing industry for opioid / opiate and benzodiazepine drug classes. Perceived non-compliance can have very negative consequences for a patient, including being discharged from an Addiction Recovery program or being falsely accused of misuse or diversion of a prescribed pain management medication.
30 Day Account Integration – LabSource Quickly Communicates Issues That Can Affect Testing and Turn-Around Time.
Solid Phase Extraction & Concentrate Eliminates Interferences and Extracts Drugs to Increase Sensitivity. Evaporates Liquid Leaving High Concentrations of Drugs for Maximum Sensitivity.
Patient Results are Compared to the Patient’s Previous Results.
Automatic Re-test and Verification of Unexpected Results; We Re-test 10% of Specimens.